At present, there is no established consensus on the treatment of Philadelphia chromosome-positive Ph + MPAL, and reports on cases with the atypical e13a3 BCR::ABL1 fusion are particularly scarce. Here, ABL1 is linked to mixed phenotype acute leukemia.